SignatureFD’s Arcutis Biotherapeutics ARQT Stock Holding History

SignatureFD’s Portfolio ARQT Stock Details ARQT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$50.6K	Hold	2,147	–	–	﹤0.01%	1710
2025 Q4	$62.3K	Buy	2,147 +10	+0.5%	+$256	﹤0.01%	1525
2025 Q3	$40.3K	Hold	2,137	–	–	﹤0.01%	1754
2025 Q2	$30K	Sell	2,137 -1,413	-40%	-$19.8K	﹤0.01%	1873
2025 Q1	$55.5K	Buy	3,550 +55	+2%	+$775	﹤0.01%	1508
2024 Q4	$48.7K	Hold	3,495	–	–	﹤0.01%	1602
2024 Q3	$32.5K	Hold	3,495	–	–	﹤0.01%	1819
2024 Q2	$32.5K	Sell	3,495 -24	-0.7%	-$217	﹤0.01%	1733
2024 Q1	$34.9K	Buy	+3,519	New	+$26.3K	﹤0.01%	1730
2023 Q4	–	Sell	-346	Closed	-$1.84K	–	3133
2023 Q3	$1.84K	Sell	346 -22	-6%	-$187	﹤0.01%	2793
2023 Q2	$3.51K	Buy	368 +250	+212%	+$2.77K	﹤0.01%	2634
2023 Q1	$1.3K	Sell	118 -174	-60%	-$2.52K	﹤0.01%	2924
2022 Q4	$4.32K	Sell	292 -44	-13%	-$769	﹤0.01%	2538
2022 Q3	$6K	Sell	336 -49	-13%	-$1.11K	﹤0.01%	2309
2022 Q2	$8K	Buy	385 +93	+32%	+$1.91K	﹤0.01%	2205
2022 Q1	$6K	Buy	292 +282	+2,820%	+$4.77K	﹤0.01%	2379
2021 Q4	$0	Sell	10 -585	-98%	-$11.6K	﹤0.01%	3098
2021 Q3	$14K	Buy	+595	New	+$13.6K	﹤0.01%	1897

Other funds holding ARQT

Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return